Tracked deals
6
6 tracked deals across 2019-2026.
Biotechnology Buyers & Acquisitions in Illinois
Buyer mix
Strategic-led
6 strategic · 2 pe
Top trend
Volume peaked in 2021
2 tracked deals announced in 2021.
Buyer Snapshot
Top Buyers
Illustrative buyers pulled from tracked transactions on this page. This table is capped and intentionally non-exhaustive.
| Buyer | # Deals | Focus | Type |
|---|---|---|---|
| Ampersand Capital Partners | 1 | Middle-market private equity firm focused on growth-orien... | PE |
| Charles River Laboratories International, Inc. | 1 | Provider of preclinical and clinical laboratory services,... | Strategic |
| Cyrus Biotechnology, Inc. | 1 | Pre-clinical-stage biotechnology company combining comput... | Strategic |
| Novo Holdings A/S | 1 | Holding and investment company managing the Novo Nordisk ... | PE |
| Transnetyx | 1 | Provider of automated genotyping and research-support lab... | Strategic (PE-backed) |
| Zara Merger Sub Inc. | 1 | Wholly owned acquisition subsidiary of Zydus used to exec... | Strategic |
| Zydus Lifesciences Limited | 1 | Integrated pharmaceutical company focused on building spe... | Strategic |
| Zydus Worldwide DMCC | 1 | Corporate acquisition subsidiary used by Zydus to acquire... | Strategic |
Acquisition Volume in Biotechnology in Illinois by Year
Last 5 years
Actual
Full-year estimate
Supporting Data
Recent Transactions
-
May 13, 2026
- Buyer
- Zydus Worldwide DMCC, Zydus Lifesciences Limited, Zara Merger Sub Inc.
- Target
- Assertio Holdings, Inc.
- Industry
- Biotechnology
- Location
- Illinois, United States
- Type
- Buyout
Zydus Worldwide DMCC, a subsidiary of Zydus Lifesciences Limited, has entered into a definitive agreement to acquire all outstanding shares of Assertio Holdings, Inc. for $23.50 per share in cash, valuing the deal at approximately $166.4 million. The transaction is structured as a tender offer followed by a second-step merger at the same price and is expected to close in the second quarter of 2026 (2026–27 financial year in some reports), subject to customary conditions.
-
March 19, 2024
- Buyer
- Ampersand Capital Partners
- Target
- Biologos LLC
- Industry
- Biotechnology
- Location
- Illinois, United States
- Type
- Buyout
Ampersand Capital Partners, a healthcare-focused private equity firm, has acquired Biologos LLC, a Glendale Heights, Illinois-based manufacturer of custom and standard cell culture media, reagents, buffers, enzymes, and sera. Ampersand will invest to expand Biologos' capabilities, product offerings, and geographic reach, and has appointed Frank Witney as Chairman with two Ampersand principals joining the board.
-
January 30, 2023
- Buyer
- Charles River Laboratories International, Inc.
- Target
- SAMDI Tech, Inc.
- Industry
- Biotechnology
- Location
- Illinois, United States
- Type
- Buyout
Charles River Laboratories acquired the remaining 80% stake in SAMDI Tech for $50 million in cash, completing a transaction that follows a partnership begun in 2018. The acquisition integrates SAMDI Tech's proprietary mass spectrometry high-throughput screening technology into Charles River's Discovery and Safety Assessment segment to strengthen drug discovery capabilities and accelerate hit identification for pharmaceutical and biotech clients.
-
- Buyer
- Cyrus Biotechnology, Inc.
- Target
- Orthogonal Biologics
- Industry
- Biotechnology
- Location
- Illinois, United States
- Type
- Buyout
Cyrus Biotechnology completed an acquisition of Orthogonal Biologics and closed an $18 million Series B financing to build an integrated software-and-screening pre-clinical biologics discovery firm. The financing was led by a syndicate including OrbiMed Advisors, Trinity Ventures, Agent Capital and other investors, with Selecta Bioscience joining as a strategic investor; the acquisition brings Orthogonal’s deep mutational scanning protein engineering capabilities into Cyrus’s computational discovery platform.
-
February 8, 2021
- Buyer
- Transnetyx
- Target
- BrainBits
- Industry
- Biotechnology
- Location
- Illinois, United States
- Type
- Addon
Transnetyx, a Memphis-area provider of automated genotyping and research support services, has acquired BrainBits, a Springfield, Illinois supplier of fresh, micro-dissected rodent brain and other tissues. The acquisition expands Transnetyx's product and tissue-service offerings for university, hospital and bioscience researchers and brings BrainBits operations into the Transnetyx Tissue brand.
-
August 6, 2019
- Buyer
- Novo Holdings A/S
- Target
- LanzaTech
- Industry
- Biotechnology
- Location
- Illinois, United States
- Type
- Growth capital
Novo Holdings A/S made a $72 million Series E growth equity investment in LanzaTech to support expansion and commercialization of the company's carbon-recycling fuels and chemicals platform. Anders Bendsen Spohr of Novo Holdings will join LanzaTech's board as the investment aims to accelerate deployment of LanzaTech's sustainable fuels, chemicals and polyethylene produced from recycled carbon.
Build a buyer list for your Biotechnology deal
Find buyers actively acquiring biotechnology companies.
Related Acquisition Pages
Biotechnology Buyers & Acquisitions
Biotechnology Buyers & Acquisitions in Canada
Private Equity-Backed Biotechnology Buyers
Biotechnology Acquisitions in 2026
Biotechnology Acquisitions in 2024
Biotechnology Acquisitions in 2023
Biotechnology Acquisitions in 2021
Biotechnology Acquisitions in 2019
Acquisitions in Illinois
Private Equity-Backed Acquisitions in Illinois
Acquisitions in Illinois in 2026
Acquisitions in Illinois in 2024